Sarepta Therapeutics (SRPT) Reports Q4 Loss, Tops Revenue Estimates
1/3 23:55
Sarepta Therapeutics (SRPT) came out with a quarterly loss of $1.42 per share versus the Zacks Consensus Estimate of a loss of $1.51. This compares to loss of $2.40 per share a year ago. These figures are adjusted for non-recurring items....